Thiazolidinediones lower the risk of pneumonia in patients with type 2 diabetes

DiscussionThis cohort study demonstrated that TZD use was associated with significantly lower risks of hospitalization for pneumonia, invasive mechanical ventilation, and death due to pneumonia in patients with T2D. Higher cumulative duration and dose of pioglitazone were associated with a further lower risk of outcomes.
Source: Frontiers in Microbiology - Category: Microbiology Source Type: research